Low-Density Lipoprotein Cholesterol Is Associated With Insulin Secretion

CONTEXT: Pharmacological lowering of low-density lipoprotein (LDL) cholesterol potently reduces cardiovascular risk while concurrently increasing type 2 diabetes risk. OBJECTIVE: The aim of this study was to investigate the relationship between LDL cholesterol concentrations and insulin secretion an...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Clin Endocrinol Metab
Auteurs principaux: Dannecker, Corinna, Wagner, Robert, Peter, Andreas, Hummel, Julia, Vosseler, Andreas, Häring, Hans-Ulrich, Fritsche, Andreas, Birkenfeld, Andreas L, Stefan, Norbert, Heni, Martin
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2021
Sujets:
Clinical Research Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8118579/
https://ncbi.nlm.nih.gov/pubmed/33693827
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/clinem/dgab147
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires